23 August 2004
BOXMEER (The Netherlands)
WESTBROOK, Maine, TBD, 2004-08-23—The Production Animal Services group of IDEXX Laboratories, Inc. (NASDAQ: IDXX), signed an agreement on August 17, 2004, for the purchase of Dr. Bommeli AG, a company of the Dutch animal health company Intervet. Based in Liebefeld-Bern, Switzerland, Bommeli is an internationally recognized leader in the veterinary diagnostic market offering state-of-the-art diagnostic reagents and testing for the control of livestock diseases. The acquisition is expected to be completed later this year, upon receiving the necessary regulatory approvals in Europe.
“Combining the resources, technical knowledge and best practices of both organizations provides compelling opportunities for our customers, our employees and our businesses,” commented Dr. Quentin Tonelli, Vice President, IDEXX Laboratories. “The Bommeli CHEKiT® line of enzyme linked immunosorbent assay products has an outstanding reputation in the European market, and greatly complements the IDEXX product portfolio. The synergies which exist between our companies, coupled with IDEXX’s strong commitment toward research and development, will result in a broader portfolio of products to address our customer’s long-term diagnostic needs.”
